Project Grant HT94252410663
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Shreveport, LA 71103, USA
Similar Awards
This $2,997,922 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research at Florida State University (FSU) to develop rapid, non-invasive brain stimulation treatments for post-traumatic stress disorder (PTSD). The award, which runs from September 30, 2024 to September 29, 2028, will enable FSU's Sponsored Research Administration division to conduct cutting-edge scientific studies to advance...
This federal Project Grant award of $2,217,454.00, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports a research study on the effects of transcranial photobiomodulation (PBM) in older adults with traumatic brain injury. The primary awardee is the Research Foundation of the City University of New York, which is collaborating with New York University School of Medicine as a sub-grantee. The research aims to...
This federal Project Grant award, valued at $3,141,404.00 and issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized controlled trial to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for the treatment of post-traumatic stress disorder (PTSD). The award was granted to Rush University Medical Center, a prominent academic medical center in Chicago, Illinois, to conduct this...
This $4,208,345.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a hybrid 1 effectiveness-implementation trial of partner-assisted prolonged exposure for post-traumatic stress disorder (PTSD). The awardee, the Regents of the University of Minnesota, will leverage its expertise in medical research to conduct this investigation at the University of Minnesota in Minneapolis, MN. The award period runs from...
The U.S. Defense Health Agency awarded a $2,534,532 Project Grant to Rush University Medical Center to evaluate evidence-based options for initial PTSD treatment non-responders. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a comprehensive range of biomedical research initiatives aimed at improving health outcomes for military service members, veterans, and the broader public. The award has a performance period of September 1,...
This federal Project Grant award, valued at $707,436.00 and provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports research at the Albert Einstein College of Medicine to investigate biomarker signatures related to post-traumatic epileptogenesis (PTEGENESIS) and treatments. The project has an award date of May 1, 2025 and an ultimate completion date of April 30, 2027. Additionally, the award includes a sub-grant...
This $2,763,615 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of brief prolonged exposure therapy for injured individuals admitted to a Level I trauma center. The goal is to evaluate the effectiveness of this approach in preventing post-traumatic stress disorder (PTSD) in this patient population. The 4-year study is being conducted by the Baylor Research Institute, a non-profit...
This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
The Department of the Army Medical Command awarded a $2,008,900 project grant to the Veterans Medical Research Foundation of San Diego under the Military Medical Research and Development program (CFDA 12.420). The four-year project grant will fund research into combined nonpharmacological therapies for mild traumatic brain injury (mTBI)-related headaches from September 2021 through August 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
The University of Arizona was awarded a $745,766.00 Project Grant under the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct a randomized clinical trial on the use of psychiatric service dogs and prolonged exposure therapy for PTSD in military-connected populations. The award has a performance period from September 30, 2024 to September 28, 2025. As a subrecipient, the Lowcountry Center For Veterans Research will provide research support...